Trepipam (Trimopam, SCH-12679) is a D1-dopamine receptor antagonist. Trepipam can reduce the self-injurious behavior in 6-OHDA-lesioned rats. Trepipam can be used in the research of epilepsy and anxiety neurosis[1][2][3].
Molecular Weight:
297.39
CAS Number:
[20012-08-2]
Formula:
C19H23NO2
Target:
Dopamine Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted